Clinical Trials on Ovarian Cancer (Epithelial) in United Kingdom
Total 29961 results
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity Cancer | Fallopian Tube AdenocarcinomaUnited States
-
CelgeneGynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
Eli Lilly and CompanyCompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
University of Maryland, College ParkCompleted
-
AstraZenecaCompletedOvarian CancerUnited Arab Emirates
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnOvarian CancerUnited States
-
University of South AlabamaMayo Clinic; Washington University School of Medicine; Tulane University Health... and other collaboratorsCompletedOvarian CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedOvarian CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedOvarian CancerUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
University of PennsylvaniaCompleted
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterKeryx BiopharmaceuticalsCompletedOvarian CancerUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Withdrawn
-
M.D. Anderson Cancer CenterTerminatedOvarian CancerUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
MEI Pharma, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Australia
-
Innovation Pharmaceuticals, Inc.Completed
-
Fujirebio Diagnostics, Inc.Completed
-
GlaxoSmithKlineCompleted
-
Astellas Pharma IncCompletedOvarian Cancer | Solid TumorsUnited States, United Kingdom, Australia, Canada, Switzerland, Czechia, Italy, Poland, Romania, Russian Federation
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingFallopian Tube Cancer | Solid Tumor | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Australia, Bulgaria, Bosnia and Herzegovina, Georgia, Korea, Republic of, Serbia
-
zr Pharma & GmbHFoundation MedicineCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited Kingdom, United States, Israel, Spain, Italy, Czechia, Canada, Hungary, Poland, Russian Federation, Brazil, Ukraine
-
NanOlogy, LLCUS Biotest, Inc.TerminatedOvarian CarcinomaUnited States
-
Duke UniversityCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
Hoosier Cancer Research NetworkBoehringer IngelheimTerminated
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedQuality of Life | Ovarian Cancer | Malignant Tumor of PeritoneumUnited States
-
William CarsonCompletedHepatocellular Carcinoma | Unspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell TumorUnited States
-
AA SecordBoehringer IngelheimCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Michael McHaleVerastem, Inc.; Nine Girls AskRecruitingROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAKOvarian CancerUnited States
-
Winthrop University HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterTerminatedOvarian Cancer | Sexual DysfunctionUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedSolid TumorsUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
ImmunoGen, Inc.Active, not recruitingFallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Ovarian CancerUnited States, United Kingdom, Belgium, Spain, Canada, Georgia
-
Dana-Farber Cancer InstituteAstraZenecaTerminatedRecurrent Ovarian Carcinoma | Recurrent Cervical Carcinoma | Recurrent Endometrial Cancer | Metastatic Endometrial Cancer | Metastatic Cervical Cancer | Recurrent Vaginal Cancer | Recurrent Vulvar Cancer | Metastatic Ovarian Cancer | Recurrent Gynecological Cancer | Metastatic Vaginal Cancer | Metastatic...United States
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCCompletedOvarian Cancer | Endometrial CancerUnited States
-
European Organisation for Research and Treatment...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerFrance, Spain, Netherlands, Australia, United Kingdom, Italy, Portugal, Austria
-
NYU Langone HealthGenentech, Inc.; University of New Mexico Cancer CenterCompleted
-
Emory UniversityCompletedHereditary Breast and Ovarian CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Stage IIA Fallopian Tube Cancer | Stage... and other conditionsUnited States
-
University of PennsylvaniaFox Chase Cancer CenterCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
Eli Lilly and CompanyCompletedOvarian CancerUnited States, Israel, Spain, Korea, Republic of, Australia, Belgium, United Kingdom, Italy
-
CytranUnknownOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
Women and Infants Hospital of Rhode IslandTerminatedBreast Cancer | Ovarian CancerUnited States
-
Mateon TherapeuticsTerminatedPlatinum Resistant Ovarian CancerUnited States, Belgium, Germany
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States